From diagnosis to treatment to follow up care, UT Southwestern’s multidisciplinary team of specialized and internationally-renowned kidney cancer doctors delivers exceptional and compassionate patient care. With over 20 specialized physicians and more than 60 affiliated laboratories, the UT Southwestern Kidney Cancer Program (KCP) is paving the way for tailored treatments.
Analyses of UTSW KCP patient survival rates by the Office of Health System Affairs show superior survival rates compared to national benchmarks across all kidney cancer stages, and the results are statistically significant for 3 out of the 4 stages. Five-year survival rates for patients with stage I are 88 percent vs. 82 percent, for stage II, 85 percent vs. 77 percent, and for stage III, 72 percent vs. 64 percent. For stage IV kidney cancer patients, survival rates at the KCP are more than double the national benchmark (25 percent vs. 11 percent). Thus, whereas patients with stage IV kidney cancer have a 1 in 10 chance of being alive at 5 years, at the KCP, the odds are 1 in 4.
As a referral center, UT Southwestern attracts particularly complex cases, and as such, the results may be even more impressive.
While nationwide, kidney cancer is the seventh most common cancer in men and the 10th in women, kidney cancer is the fourth most common malignancy at the Harold Simmons Comprehensive Cancer Center. Patients come to the KCP not only from North Texas, but throughout neighboring states and beyond. According to the Dallas-Fort Worth Hospital Council, the KCP serves the most patients with this condition than any other program in Dallas/Ft. Worth.
